The most popular nasal decongestant on U.S. pharmacy shelves may not be there much longer. The Food and Drug Administration recently announced plans to phase out phenylephrine, the key ingredient some cold and allergy pills.

Summary

The FDA has proposed phasing out oral phenylephrine, a common decongestant in cold medicines like Sudafed PE and DayQuil, after studies showed it is no more effective than a placebo.

The drug, ineffective when swallowed due to breakdown in the stomach, remains usable in nasal sprays.

Alternatives include pseudoephedrine, nasal sprays, and steroid treatments like Flonase.

The regulatory process to remove phenylephrine could take over a year, but experts argue removing ineffective options will help consumers choose better remedies for congestion. Drugmakers are expected to challenge the proposal.

  • AggravationstationEnglish
    2·
    3 days ago

    There’s another ingredient in Sudafed that does a pretty damn good job of unblocking your nose, let me tell you

    • morbidcactus@lemmy.caEnglish
      2·
      3 days ago

      Yeah, the Pseudoephedrine does what it says it does, I was using Tylenol cold/Flu (daytime meds have that on it) years ago when I came down with something nasty, made me not feel like death. It’s an amphetamine so those on stim meds (like myself since then) should talk to your pharmacist first, mixing stims isn’t a great idea.